Wenjiao Zeng

814 total citations
26 papers, 606 citations indexed

About

Wenjiao Zeng is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Wenjiao Zeng has authored 26 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Wenjiao Zeng's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Wenjiao Zeng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Wenjiao Zeng collaborates with scholars based in China, Netherlands and United States. Wenjiao Zeng's co-authors include Ming-Jie Wang, Lei Cao, Tianyuan Ci, Lin Yu, Jiandong Ding, Nong Zhang, Guoyuan Liu, Hao Ding, Shengzi Wang and Chen Fu and has published in prestigious journals such as PLoS ONE, Hepatology and Biochemical and Biophysical Research Communications.

In The Last Decade

Wenjiao Zeng

26 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjiao Zeng China 13 228 106 106 94 83 26 606
Minyue Zhang China 10 190 0.8× 73 0.7× 93 0.9× 33 0.4× 72 0.9× 25 526
Ritu Khosla India 9 147 0.6× 94 0.9× 95 0.9× 82 0.9× 122 1.5× 13 416
Jinqiu Zhao China 15 198 0.9× 83 0.8× 131 1.2× 55 0.6× 31 0.4× 34 573
Mingqin Lu China 13 195 0.9× 71 0.7× 105 1.0× 86 0.9× 73 0.9× 35 528
Yizhou Zheng China 12 255 1.1× 115 1.1× 55 0.5× 66 0.7× 21 0.3× 28 504
Junjun Wang China 10 213 0.9× 142 1.3× 41 0.4× 103 1.1× 58 0.7× 34 530
David E. Smart United Kingdom 14 260 1.1× 100 0.9× 314 3.0× 129 1.4× 371 4.5× 24 910
Shuangyi Ren China 14 303 1.3× 176 1.7× 53 0.5× 153 1.6× 37 0.4× 62 657

Countries citing papers authored by Wenjiao Zeng

Since Specialization
Citations

This map shows the geographic impact of Wenjiao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjiao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjiao Zeng more than expected).

Fields of papers citing papers by Wenjiao Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjiao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjiao Zeng. The network helps show where Wenjiao Zeng may publish in the future.

Co-authorship network of co-authors of Wenjiao Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjiao Zeng. A scholar is included among the top collaborators of Wenjiao Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjiao Zeng. Wenjiao Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Fengyun, Hexige Saiyin, Pingzhao Zhang, et al.. (2023). An audit of autopsy-confirmed diagnostic errors in perinatal deaths: What are the most common major missed diagnoses. Heliyon. 9(9). e19984–e19984. 2 indexed citations
2.
Liu, Yufeng, Fengyun Zheng, Zhonghua Zhao, et al.. (2022). ZNF191 alters DNA methylation and activates the PI3K‐AKT pathway in hepatoma cells via transcriptional regulation of DNMT1. Cancer Medicine. 11(5). 1269–1280. 10 indexed citations
3.
Cheng, Xiaofang, Alan W. Varley, Guojun Qian, et al.. (2021). A host lipase prevents lipopolysaccharide-induced foam cell formation. iScience. 24(9). 103004–103004. 7 indexed citations
4.
Chen, Lei, Xiang Wang, Yufeng Liu, et al.. (2020). Cyclin Y binds and activates CDK4 to promote the G1/S phase transition in hepatocellular carcinoma cells via Rb signaling. Biochemical and Biophysical Research Communications. 533(4). 1162–1169. 12 indexed citations
5.
Liu, Yufeng, Di Wu, Lei Chen, et al.. (2020). Wnt8B, transcriptionally regulated by ZNF191, promotes cell proliferation of hepatocellular carcinoma via Wnt signaling. Cancer Science. 112(2). 629–640. 14 indexed citations
6.
Dong, Pingping, Xiaoxiao Wang, Wenqing Tang, et al.. (2020). Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma. Journal of Hepatology. 73(6). 1446–1459. 30 indexed citations
7.
Han, Han, Zihui Tang, Qian Yang, et al.. (2017). Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injury. PLoS Pathogens. 13(6). e1006436–e1006436. 45 indexed citations
8.
Liu, Danyang, et al.. (2017). Autopsy interrogation of emergency medicine dispute cases: how often are clinical diagnoses incorrect?. Journal of Clinical Pathology. 71(1). 67–71. 11 indexed citations
9.
Wang, Jie, Zuohua Tang, Shuyi Wang, et al.. (2016). Differential diagnostic value of computed tomography perfusion combined with vascular endothelial growth factor expression in head and neck lesions. Oncology Letters. 11(5). 3342–3348. 6 indexed citations
10.
Gao, Pan, Yingze Wei, Zhigang Zhang, et al.. (2016). Synergistic effects of c-Jun and SP1 in the promotion of TGFβ1-mediated diabetic nephropathy progression. Experimental and Molecular Pathology. 100(3). 441–450. 12 indexed citations
11.
Wang, Jie, Zuohua Tang, Xiaoyuan Feng, et al.. (2014). Preliminary Study of Diffusion-Weighted Imaging and Magnetic Resonance Spectroscopy Imaging in Kimura Disease. Journal of Craniofacial Surgery. 25(6). 2147–2151. 8 indexed citations
12.
13.
Ding, Hong, Jiaojiao Ma, Wenping Wang, et al.. (2014). Assessment of liver fibrosis: The relationship between point shear wave elastography and quantitative histological analysis. Journal of Gastroenterology and Hepatology. 30(3). 553–558. 24 indexed citations
14.
Yu, Lin, et al.. (2013). The thermogelling PLGA–PEG–PLGA block copolymer as a sustained release matrix of doxorubicin. Biomaterials Science. 1(4). 411–411. 86 indexed citations
15.
Liu, Guoyuan, Guanghua Li, Ying Xu, et al.. (2013). Association between IL12B polymorphisms and tuberculosis risk: A meta-analysis. Infection Genetics and Evolution. 21. 401–407. 10 indexed citations
16.
Gouw, Annette S.H., Wenjiao Zeng, Inge Platteel, et al.. (2010). Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma. Hepatology. 52(2). 540–549. 10 indexed citations
17.
Huang, Ping, Yuejuan Zhang, Tao Jiang, Wenjiao Zeng, & Nong Zhang. (2009). Aldose reductase is a potent regulator of TGF-β1 induced expression of fibronectin in human mesangial cells. Molecular Biology Reports. 37(7). 3097–3103. 11 indexed citations
18.
Huang, Ping, Yuejuan Zhang, Tao Jiang, Wenjiao Zeng, & Nong Zhang. (2009). Role of aldose reductase in the high glucose induced expression of fibronectin in human mesangial cells. Molecular Biology Reports. 37(6). 3017–3021. 6 indexed citations
19.
Zeng, Wenjiao, Annette S.H. Gouw, Marius C. van den Heuvel, et al.. (2008). The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Hepatology. 48(5). 1517–1527. 32 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026